Literature DB >> 19449355

TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression.

Melissa J Simon1, Shan Gao, Woo Hyeun Kang, Scott Banta, Barclay Morrison.   

Abstract

Although some studies have shown that the cell penetrating peptide (CPP) TAT can enter a variety of cell lines with high efficiency, others have observed little or no transduction in vivo or in vitro under conditions mimicking the in vivo environment. The mechanisms underlying TAT-mediated transduction have been investigated in cell lines, but not in primary brain cells. In this study we demonstrate that transduction of a green fluorescent protein (GFP)-TAT fusion protein is dependent on glycosaminoglycan (GAG) expression in both the PC12 cell line and primary astrocytes. GFP-TAT transduced PC12 cells and did so with even higher efficiency following NGF differentiation. In cultures of primary brain cells, TAT significantly enhanced GFP delivery into astrocytes grown under different conditions: (1) monocultures grown in serum-containing medium; (2) monocultures grown in serum-free medium; (3) cocultures with neurons in serum-free medium. The efficiency of GFP-TAT transduction was significantly higher in the monocultures than in the cocultures. The GFP-TAT construct did not significantly enter neurons. Experimental modulation of GAG content correlated with alterations in TAT transduction in PC12 cells and astrocyte monocultures grown in the presence of serum. In addition, this correlation was predictive of TAT-mediated transduction in astrocyte monocultures grown in serum free medium and in coculture. We conclude that culture conditions affect cellular GAG expression, which in turn dictates TAT-mediated transduction efficiency, extending previous results from cell lines to primary cells. These results highlight the cell-type and phenotype-dependence of TAT-mediated transduction, and underscore the necessity of controlling the phenotype of the target cell in future protein engineering efforts aimed at creating more efficacious CPPs. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449355      PMCID: PMC2729539          DOI: 10.1002/bit.22377

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  69 in total

1.  Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides.

Authors:  K Han; M J Jeon; S H Kim; D Ki; J H Bahn; K S Lee; J Park; S Y Choi
Journal:  Mol Cells       Date:  2001-10-31       Impact factor: 5.034

Review 2.  Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.

Authors:  David J Begley
Journal:  Pharmacol Ther       Date:  2004-10       Impact factor: 12.310

3.  The kinetics and tissue distribution of protein transduction in mice.

Authors:  Shi-Rong Cai; Guang Xu; Michelle Becker-Hapak; Margaret Ma; Steven F Dowdy; Howard L McLeod
Journal:  Eur J Pharm Sci       Date:  2006-01-11       Impact factor: 4.384

4.  Changes in glycosaminoglycans during the neuritogenesis in PC12 pheochromocytoma cells induced by nerve growth factor.

Authors:  R Katoh-Semba; A Oohira; S Kashiwamata
Journal:  J Neurochem       Date:  1990-11       Impact factor: 5.372

Review 5.  Barriers to carrier mediated drug and gene delivery to brain tumors.

Authors:  Grace H Huynh; Dennis F Deen; Francis C Szoka
Journal:  J Control Release       Date:  2005-11-28       Impact factor: 9.776

6.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

7.  No entry for TAT(44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides.

Authors:  S D Krämer; H Wunderli-Allenspach
Journal:  Biochim Biophys Acta       Date:  2003-01-31

8.  Quiescent astroglia in long-term primary cultures re-enter the cell cycle and require a non-sterol isoprenoid in late G1.

Authors:  T J Langan; M C Slater
Journal:  Brain Res       Date:  1991-05-10       Impact factor: 3.252

Review 9.  Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells.

Authors:  G M K Poon; J Gariépy
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

10.  Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells.

Authors:  A Rapraeger; M Jalkanen; M Bernfield
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  8 in total

1.  An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform.

Authors:  Shan Gao; Melissa J Simon; Christopher D Hue; Barclay Morrison; Scott Banta
Journal:  ACS Chem Biol       Date:  2011-02-22       Impact factor: 5.100

2.  Increased delivery of TAT across an endothelial monolayer following ischemic injury.

Authors:  Melissa J Simon; Woo Hyeun Kang; Shan Gao; Scott Banta; Barclay Morrison
Journal:  Neurosci Lett       Date:  2010-09-17       Impact factor: 3.046

3.  dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Sangho Lim; Won-Ju Kim; Yeon-Ho Kim; Sohee Lee; Ja-Hyun Koo; Jung-Ah Lee; Heeseok Yoon; Do-Hyun Kim; Hong-Jai Park; Hye-Mi Kim; Hong-Gyun Lee; Ji Yun Kim; Jae-Ung Lee; Jae Hun Shin; Lark Kyun Kim; Junsang Doh; Hongtae Kim; Sang-Kyou Lee; Alfred L M Bothwell; Minah Suh; Je-Min Choi
Journal:  Nat Commun       Date:  2015-09-15       Impact factor: 14.919

4.  Efficient therapeutic delivery by a novel cell-permeant peptide derived from KDM4A protein for antitumor and antifibrosis.

Authors:  Hu Wang; Jie-Lan Ma; Ying-Gui Yang; Yang Song; Jiao Wu; Yan-Yan Qin; Xue-Li Zhao; Jun Wang; Li-Li Zou; Jiang-Feng Wu; Jun-Ming Li; Chang-Bai Liu
Journal:  Oncotarget       Date:  2016-08-02

5.  Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.

Authors:  Bruna Dos Santos Rodrigues; Sushant Lakkadwala; Takahisa Kanekiyo; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2019-08-14

6.  SialoPen peptides are new cationic foldamers with remarkable cell permeability.

Authors:  I Abrrey Monreal; Erik M Contreras; Gary A Wayman; Hector C Aguilar; Jonel P Saludes
Journal:  Heliyon       Date:  2020-12-24

7.  A bifurcated proteoglycan binding small molecule carrier for siRNA delivery.

Authors:  Matt Gooding; Derick Adigbli; A W Edith Chan; Roberta J Melander; Alexander J MacRobert; David L Selwood
Journal:  Chem Biol Drug Des       Date:  2014-05-13       Impact factor: 2.817

8.  Polymeric microspheres as protein transduction reagents.

Authors:  David Nagel; Jonathan M Behrendt; Gwen F Chimonides; Elizabeth E Torr; Andrew Devitt; Andrew J Sutherland; Anna V Hine
Journal:  Mol Cell Proteomics       Date:  2014-04-01       Impact factor: 5.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.